ADDF - Alzheimer Drug Discovery Foundation

Founded in 1998 by co-chairmen Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's. 

Programmi di finanziamento

The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer's and related dementias.
They have dedicated their funding to several key areas:

  • Translational research to develop new drugs and build preclinical evidence
  • IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
  • Development and validation of plasma, CSF, neuroimaging and digital biomarkers
  • Epidemiological studies and comparative effectiveness research

Applications are reviewed throughout the year through their four core programs: